None
Quote | Mirati Therapeutics Inc. (NASDAQ:MRTX)
Last: | $58.70 |
---|---|
Change Percent: | -0.27% |
Open: | $58.86 |
Close: | $58.70 |
High: | $58.99 |
Low: | $58.54 |
Volume: | 20,994,430 |
Last Trade Date Time: | 01/22/2024 03:00:00 am |
News | Mirati Therapeutics Inc. (NASDAQ:MRTX)
First Solar Inc. (FSLR) is expected to report $3.19 for Q4 2023 VIZIO Holding Corp. Class A (VZIO) is expected to report $0.02 for Q4 2023 Henry Schein Inc. (HSIC) is expected to report $0.71 for Q4 2023 Republic Services Inc. (RSG) is expected to report $1.28 for Q4 2023 Forge Gl...
2024-02-06 08:19:58 ET More on Bristol-Myers Squibb Bristol-Myers Squibb: All Focus On Execution Bristol-Myers Squibb: Massive Discount Spells Opportunity Bristol-Myers Squibb Company 2023 Q4 - Results - Earnings Call Presentation Bristol Myers, 2seventy bio ...
Message Board Posts | Mirati Therapeutics Inc. (NASDAQ:MRTX)
Subject | By | Source | When |
---|---|---|---|
Thinking its tops 1,000's and 1,000's of percentages | make it happen | investorshub | 10/20/2020 1:40:36 PM |
Yeah one of the best move for real | PAC | investorshub | 10/12/2020 4:09:20 PM |
lol if held would have killed it. Now | make it happen | investorshub | 10/12/2020 1:29:38 PM |
That was years ago lol | PAC | investorshub | 10/12/2020 1:24:37 PM |
All targets hit on steroids. $2.70 to over $170.00....... | make it happen | investorshub | 10/12/2020 1:23:41 PM |
News, Short Squeeze, Breakout and More Instantly...
Mirati Therapeutics Inc. Company Name:
MRTX Stock Symbol:
NASDAQ Market:
Mirati Therapeutics Inc. Website:
First Solar Inc. (FSLR) is expected to report $3.19 for Q4 2023 VIZIO Holding Corp. Class A (VZIO) is expected to report $0.02 for Q4 2023 Henry Schein Inc. (HSIC) is expected to report $0.71 for Q4 2023 Republic Services Inc. (RSG) is expected to report $1.28 for Q4 2023 Forge Gl...
European Commission Approves KRAZATI (adagrasib) as a Targeted Treatment Option for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation PR Newswire SAN DIEGO and ZUG, Switzerland , Jan. 10, 2024 /PRNewswire/ -- Mirati The...
According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion recorded in Q2 2...